Trade Name stringlengths 3 57 ⌀ | Generic/Proper Name(s) stringlengths 4 79 | Active Ingredient(s) stringlengths 4 64 ⌀ | Cardiotoxicity stringclasses 3
values | DICT Concern stringclasses 6
values | Keywords stringlengths 5 112 ⌀ | DIC Severity Level stringclasses 5
values |
|---|---|---|---|---|---|---|
FOTIVDA | TIVOZANIB | tivozanib hydrochloride | Heart Damage | most | fatal Cardiac Failure | severe |
BALVERSA | ERDAFITINIB | Erdafitinib | Heart Damage | less | acute myocardial infarction. | severe |
Orladeyo | BEROTRALSTAT HYDROCHLORIDE | Berotralstat hydrochloride | Arrhythmia | less | QT Prolongation with Higher-Than-Recommended Dosages | moderate |
FARXIGA | DAPAGLIFLOZIN | DAPAGLIFLOZIN PROPANEDIOL | null | no | not prolong the QT interval | null |
Velphoro | SUCROFERRIC OXYHYDROXIDE | FERRIC OXYHYDROXIDE | null | no | null | null |
Macrilen | MACIMORELIN ACETATE | MACIMORELIN | Arrhythmia | most | QTc interval prolongation | moderate |
BOSULIF | BOSUTINIB MONOHYDRATE | BOSUTINIB MONOHYDRATE | Heart Damage | most | cardiac failure | severe |
Rezurock | BELUMOSUDIL | BELUMOSUDIL | Heart Damage | less | hypertension | mild |
JAKAFI | RUXOLITINIB | RUXOLITINIB | Heart Damage | most | cardiovascular death/myocardial infarction, | severe |
VERMOX | MEBENDAZOLE | mebendazole | null | no | null | null |
PARNATE | TRANYLCYPROMINE SULFATE | TRANYLCYPROMINE SULFATE | Heart Damage | less | Hypertension | mild |
WELIREG | BELZUTIFAN | BELZUTIFAN | Heart Damage | less | Hypertension | mild |
Trulance Immediate release | PLECANATIDE | Plecanatide | null | no | null | null |
Xyrem | SODIUM OXYBATE | SODIUM OXYBATE | null | no | null | null |
Qulipta | ATOGEPANT | ATOGEPANT | null | no | not prolong the QTc interval | null |
Gleostine | LOMUSTINE | LOMUSTINE | null | no | null | null |
Incruse Ellipta | UMECLIDINIUM | UMECLIDINIUM BROMIDE | Arrhythmia | less | supraventricular tachycardia | moderate |
Cefditoren Pivoxil | CEFDITOREN PIVOXIL | CEFDITOREN PIVOXIL | null | no | null | null |
Lysodren | MITOTANE | mitotane | null | no | null | null |
DIURIL | CHLOROTHIAZIDE | CHLOROTHIAZIDE | Heart Damage | less | Hypotension | mild |
CRIXIVAN | INDINAVIR SULFATE | INDINAVIR SULFATE | Heart Damage | less | myocardial infarction | severe |
EVRYSDI | RISDIPLAM | RISDIPLAM | null | no | null | null |
Reyvow | LASMIDITAN | lasmiditan | Mixed | less | palpitations/increase blood pressure | mild |
Horizant | GABAPENTIN ENACARBIL | gabapentin enacarbil | null | no | not prolong QT interval | null |
Emcyt | ESTRAMUSTINE PHOSPHATE SODIUM | ESTRAMUSTINE PHOSPHATE SODIUM | Heart Damage | most | myocardial infarction | severe |
Nucynta ER | TAPENTADOL HYDROCHLORIDE | TAPENTADOL HYDROCHLORIDE | Heart Damage | less | hypotension | mild |
CAPLYTA | LUMATEPERONE | LUMATEPERONE | Heart Damage | less | hypotension | mild |
KOSELUGO | SELUMETINIB | SELUMETINIB | Heart Damage | most | Cardiomyopathy | severe |
TAZVERIK | TAZEMETOSTAT | tazemetostat hydrobromide | null | no | not prolong the QTc interval | null |
Mulpleta | LUSUTROMBOPAG | LUSUTROMBOPAG | null | no | not prolong the QTc interval | null |
Vascepa | ICOSAPENT ETHYL | ICOSAPENT ETHYL | Arrhythmia | less | atrial fibrillation/atrial flutter | mild |
Cotellic | COBIMETINIB | COBIMETINIB FUMARATE | Heart Damage | most | Cardiomyopathy | severe |
MOVANTIK | NALOXEGOL OXALATE | NALOXEGOL OXALATE | null | no | not prolong the QTc interval | null |
Cedax | CEFTIBUTEN DIHYDRATE | Ceftibuten dihydrate | null | no | null | null |
COPIKTRA | DUVELISIB | DUVELISIB | null | no | QTc interval were not observed | null |
Verzenio | ABEMACICLIB | abemaciclib | null | ambiguous | cardiac failure(drug Combination ) | severe |
Lithium | LITHIUM | Lithium Citrate | Mixed | most | myocarditis/prolonged QT interval | severe |
INGREZZA | VALBENAZINE | VALBENAZINE TOSYLATE | Arrhythmia | most | prolong the QT interval | severe |
Xospata | GILTERITINIB | GILTERITINIB FUMARATE | Arrhythmia | most | prolong the QT interval | severe |
PONVORY | PONESIMOD | Ponesimod | Mixed | less | Atrioventricular Conduction Delays/Increased Blood Pressure | mild |
Orilissa | ELAGOLIX | ELAGOLIX SODIUM | null | no | not prolong the QTc interval | null |
ZOLINZA | VORINOSTAT | VORINOSTAT | Heart Damage | less | myocardial infarction | severe |
Varubi | ROLAPITANT | ROLAPITANT HYDROCHLORIDE | null | no | not prolong the QTc interval | null |
IMPAVIDO | MILTEFOSINE | MILTEFOSINE | null | no | not prolong the QTc interval | null |
Xalkori | CRIZOTINIB | CRIZOTINIB | Arrhythmia | most | QT Interval Prolongation | moderate |
Ayvakit | AVAPRITINIB | avapritinib | Heart Damage | less | cardiac failure | severe |
Vizimpro | DACOMITINIB | DACOMITINIB | null | no | no large effect on QTc | null |
IBSRELA | TENAPANOR HYDROCHLORIDE | TENAPANOR HYDROCHLORIDE | null | no | not prolong the QTc interval | null |
Xofluza | BALOXAVIR MARBOXIL | BALOXAVIR MARBOXIL | null | no | not prolong the QTc interval | null |
Thalomid | THALIDOMIDE | THALIDOMIDE | Mixed | most | myocardial infarction/Bradycardia | severe |
MOTEGRITY | PRUCALOPRIDE | PRUCALOPRIDE SUCCINATE | null | no | not prolong the QTc interval | null |
PROMACTA | ELTROMBOPAG OLAMINE | ELTROMBOPAG OLAMINE | null | no | not prolong the QTc interval | null |
ERLEADA | APALUTAMIDE | Apalutamide | Heart Damage | most | ischemic cardiovascular
events | severe |
Lithostat | ACETOHYDROXAMIC ACID | ACETOHYDROXAMIC ACID | Arrhythmia | less | Palpitations | mild |
Rinvoq | UPADACITINIB | upadacitinib | Heart Damage | most | sudden cardiovascular death | severe |
Sular | NISOLDIPINE | NISOLDIPINE | Mixed | less | congestive heart failure/supraventricular
tachycardia | severe |
Mavenclad | CLADRIBINE | Cladribine | Heart Damage | most | life-threatening acute
cardiac failure | severe |
EGATEN | TRICLABENDAZOLE | TRICLABENDAZOLE | Arrhythmia | most | prolongation of the mean QTc interval | severe |
Peganone | ETHOTOIN | ETHOTOIN | null | no | null | null |
NINLARO | IXAZOMIB | ixazomib citrate | null | no | not prolong the QTc interval | null |
Viberzi | ELUXADOLINE | ELUXADOLINE | null | no | not prolong the QTc interval | null |
BAFIERTAM | MONOMETHYL FUMARATE | monomethyl fumarate | null | no | not prolong the QTc interval | null |
Zelnorm | TEGASEROD | tegaserod | null | ambiguous | patients has increased risk of developing an adverse cardiovascular event | null |
ISENTRESS | ISENTRESS | RALTEGRAVIR POTASSIUM | null | no | not prolong QT interval | null |
Ofev | NINTEDANIB | NINTEDANIB ESYLATE | Heart Damage | most | Myocardial infarction | severe |
Prilosec | OMEPRAZOLE MAGNESIUM | OMEPRAZOLE MAGNESIUM | Mixed | less | Chest pain or angina/ tachycardia | moderate |
Gilotrif | AFATINIB | AFATINIB | null | no | No large changes in the mean QTc interval | null |
Rubraca | RUCAPARIB | rucaparib camsylate | Mixed | less | ischemic cardiovascular events | severe |
OXBRYTA | VOXELOTOR | Voxelotor | null | no | not prolong QT interval | null |
ELIQUIS | APIXABAN | APIXABAN | Heart Damage | less | hypotension | mild |
Tradjenta | LINAGLIPTIN | LINAGLIPTIN | Heart Damage | most | heart failure | severe |
ZEPOSIA; ZEPOSIA 7-Day Starter Pack; ZEPOSIA Starter Kit | OZANIMOD HYDROCHLORIDE | OZANIMOD HYDROCHLORIDE | Mixed | less | Atrioventricular Conduction Delays/Increased Blood Pressure | mild |
Cystadane | BETAINE | BETAINE | null | no | null | null |
RIDAURA | AURANOFIN | AURANOFIN | null | no | null | null |
TAGRISSO | OSIMERTINIB | OSIMERTINIB | Mixed | most | cardiomyopathy/QTc Interval Prolongation | severe |
EXKIVITY | MOBOCERTINIB | Mobocertinib | Mixed | most | life-threatening heart rate-corrected QT (QTc) prolongation/cardiomyopathy | severe |
Darvon-N | PROPOXYPHENE NAPSYLATE | propoxyphene napsylate | Heart Damage | less | hypotension | mild |
ADDYI | FLIBANSERIN | Flibanserin | Heart Damage | less | hypotension | mild |
Fetzima | LEVOMILNACIPRAN HYDROCHLORIDE | LEVOMILNACIPRAN HYDROCHLORIDE; levomilnacipran hydrochloride | Mixed | less | Increased heart rate/Elevated Blood Pressure | mild |
Seysara | SARECYCLINE HYDROCHLORIDE | SARECYCLINE HYDROCHLORIDE | null | ambiguous | Intracranial hypertension | null |
Marplan | ISOCARBOXAZID | ISOCARBOXAZID | Heart Damage | less | Hypotension | mild |
PREZISTA | DARUNAVIR | darunavir ethanolate | null | no | not affect the QT/QTc interval | null |
SAVAYSA | EDOXABAN TOSYLATE | EDOXABAN TOSYLATE | null | no | not affect the QT/QTc interval | null |
XPOVIO | SELINEXOR | selinexor | Heart Damage | less | cardiac failure | severe |
Fexinidazole | FEXINIDAZOLE | FEXINIDAZOLE | Arrhythmia | most | prolong the QT interval | severe |
Pretomanid | PRETOMANID | Pretomanid | null | ambiguous | QT prolongation with the combination | null |
Rukobia | FOSTEMSAVIR TROMETHAMINE | FOSTEMSAVIR TROMETHAMINE | Arrhythmia | less | QTc Prolongation with Higher than Recommended Dosages | moderate |
XURIDEN | URIDINE TRIACETATE | uridine triacetate | null | no | null | null |
BYLVAY | ODEVIXIBAT | odevixibat | null | no | null | null |
LUPKYNIS | VOCLOSPORIN | VOCLOSPORIN | Mixed | most | prolongs the QTc interval/Hypertension | moderate |
DOJOLVI | TRIHEPTANOIN | TRIHEPTANOIN | null | no | null | null |
Cesamet | NABILONE | NABILONE | Mixed | less | tachycardia/hypotension | mild |
Rexulti | BREXPIPRAZOLE | brexpiprazole | Heart Damage | less | Hypotension | mild |
NOURIANZ | ISTRADEFYLLINE | istradefylline | null | no | not affect the QT/QTc interval | null |
FINTEPLA | FENFLURAMINE | FENFLURAMINE | Heart Damage | most | valvular heart disease | severe |
Recorlev | LEVOKETOCONAZOLE | LEVOKETOCONAZOLE | Arrhythmia | most | life-threatening ventricular dysrhythmias | severe |
LUMAKRAS | SOTORASIB | SOTORASIB | Mixed | less | cardiac arrest /cardiac failure | severe |
Nardil | PHENELZINE SULFATE | PHENELZINE SULFATE | Heart Damage | less | changes in blood pressure | mild |
Arakoda | TAFENOQUINE | TAFENOQUINE | null | ambiguous | mean increase in the QTcF interval less than 20 msec. | null |
ERIVEDGE | VISMODEGIB | VISMODEGIB | null | no | not prolong QT interval | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.